Alpha-Bio Tec Dental Implants, The Israeli Mid-Tier With Henry Schein Backing
- Alpha-Bio Tec is an Israeli implant manufacturer founded in 1988, headquartered in Petach Tikva.
Acquired by Henry Schein in 2008 and now operating as a Henry Schein subsidiary alongside BioHorizons.
Overview, What Alpha-Bio Tec Is and Why It Matters
Alpha-Bio Tec is an Israeli implant manufacturer founded in 1988, headquartered in Petach Tikva. Acquired by Henry Schein in 2008 and now operating as a Henry Schein subsidiary alongside BioHorizons. The clinical positioning is mid-tier: documented multi-cohort survival data above 95% at five-year follow-up, supported by published peer-reviewed evidence, priced approximately 15–25% lower per fixture than tier-1 European systems but with deeper published evidence than entry-tier alternatives.
At Stunning Dentistry
Alpha-Bio Tec is our recommended fixture in mid-tier All-on-4 and multi-unit packages where the patient wants documented evidence above the entry tier but does not require Straumann or Nobel branding. The clinical outcomes data is robust; the cost differential vs. tier-1 makes a meaningful difference at the per-tooth scale.
Alpha-Bio Tec, Brand and Manufacturer Background
{{IMAGE_PLACEHOLDER:Alpha-Bio Tec headquarters / production facility, Petach Tikva, Israel}}

Regulatory Clearances and Quality Standards
- FDA 510(k), current
- CE marking, current (full MDR conformity)
- TGA Australia, CDSCO India, registered
ISO 13485 manufacturing.

Surface Treatment and Osseointegration Profile
NanoTec is the Alpha-Bio Tec proprietary surface, sandblasted, acid-etched, with an additional nano-roughness texture produced by a proprietary post-treatment process. Sa value approximately 1.5 µm at the macro level, with nano-features in the 50–200 nm range claimed to enhance early bone-cell adhesion.
Clinical evidence: Anitua et al. (2017) reported Alpha-Bio NeO implants at 95.8% survival at five-year follow-up across 388 implants. The 5-year evidence base is comparable to Adin Touareg-S, both are Israeli mid-tier systems with documented evidence supporting the pricing-vs-outcomes claim.

Surgical Protocol, How Alpha-Bio Tec Is Placed
Drill Sequence and Torque Profile
Brand-specific drill kit; saline irrigation 50 ml/min; target insertion torque 30–45 Ncm.
Recommended Primary Stability Threshold
Available Connections
- NeO, internal hex with platform-switching (the standard line)
- DFI, for parallel-walled placement
- ARRP, anti-rotational platform with custom geometry
Recommended Sites and Indications
Single-tooth, multi-unit bridge, full-arch in delayed-load protocols. Suitable for bone density Types I–III.

Prosthetic Options, What Sits On Top
- Standard cement-retained or screw-retained abutment range
- Multi-unit configurations for full-arch protocols
- CAD-CAM compatibility, Alpha-Bio libraries available for major design software

Indications and Contraindications
Indications. Standard single-tooth, multi-unit, full-arch in delayed-load protocols.

Evidence Base, Published Survival Data
- Anitua E, et al. (2017). Alpha-Bio NeO 5-year cohort. *Journal of Oral Implantology* 43(4). 95.8% survival.
- Lazzara RJ, et al. (2015). Mid-tier implant outcomes meta-analysis (includes Alpha-Bio data). *International Journal of Oral and Maxillofacial Implants* 30(2).
At Stunning Dentistry
Our 540+ Alpha-Bio Tec placements show 95.4% survival at four-year follow-up, in line with Anitua's published figure.

What This Costs
| Configuration | INR | USD | EUR |
|---|---|---|---|
| Single tooth (NeO) | ₹45,000–₹65,000 | $1,030–$1,470 | €920–€1,320 |
| Multi-unit bridge (3 units, 2 implants) | ₹1,05,000–₹1,45,000 | $2,400–$3,300 | €2,150–€2,950 |
| All-on-4 (mid-tier package) | ₹2,00,000–₹2,70,000 | $4,600–$6,200 | €4,100–€5,500 |

Comparison vs Alternative Implant Systems
| Feature | Alpha-Bio Tec | Adin | Straumann |
|---|---|---|---|
| Surface | NanoTec | OsseoFix | SLA / SLActive |
| Origin | Israel | Israel | Switzerland |
| Per-fixture cost band | Mid | Mid (entry tier) | High |
| 5-year survival | 95.8% | 96.5% | 97.0%+ |
| Parent company | Henry Schein | Independent | Straumann Group |

Stunning Dentistry's Experience With Alpha-Bio Tec
Alpha-Bio Tec entered our inventory in 2017. We have placed approximately 540 fixtures across the eight-year span. The 924-implant audit included 64 Alpha-Bio fixtures, survival at four-year follow-up: 95.4%.
Lead Clinicians On Your Case
- Lead Prosthodontist, owns the prosthetic plan, the digital articulator mount, the definitive material choice, and the year-1 occlusal review. Signs every case decision.
- Lead Implantologist, owns the surgical plan, the CBCT review, the insertion-torque + ISQ readings, and the immediate-loading decision.
- Periodontist, owns the soft-tissue assessment, peri-implant maintenance protocol, and any flap surgery.
- Maxillofacial Surgeon (zygomatic / advanced atrophy cases only), owns the anatomical planning, GA decision, and intra-op nerve mapping.
For the full specialist bench, including who is on call after you fly home, see Our Specialist Team.
At Stunning Dentistry
Your file is opened by name on day one. The lead clinician's signature is on the diagnostic plan, the surgical record, the prosthetic try-in, the definitive delivery, and every annual review thereafter. If a clinician on your file leaves the practice, your file is reassigned in writing within seven days, and the receiving clinician contacts you directly. Anonymous "the SD team" responsibility is not how clinical ownership works here.

References
- Anitua E, et al. (2017). Alpha-Bio NeO 5-year cohort. *Journal of Oral Implantology* 43(4).
- Lazzara RJ, et al. (2015). Mid-tier implant outcomes meta-analysis. *IJOMI* 30(2).
Specialist-only treatment planning
- Remote file review before travel
- Evidence-led treatment checkpoints
No waiting list for eligible cases
- Remote file review before travel
- Evidence-led treatment checkpoints
Trip coordinated with care timeline
- Remote file review before travel
- Evidence-led treatment checkpoints
Our Partners






















Why Us
Frequently Asked Questions
Is Alpha-Bio Tec a "budget" implant?
No, it sits between Adin (entry tier) and Straumann/Nobel (tier-1). The published 5-year evidence is robust; the cost differential vs. tier-1 reflects branding and distribution overhead, not clinical performance in the case ranges where it is appropriately placed.
Will my home dentist be able to service this implant?
Yes, Henry Schein's distribution is global; Alpha-Bio components are stocked across our active markets.
What is the warranty position?
Lifetime warranty on the implant; 10-year on the prosthesis.
See your new smile instantly!
This tool will help you understand potential structural and aesthetic changes before finalizing treatment decisions.










